Cochlear

Cochlear Capital Intensity

The Capital Intensity Ratio of Cochlear (COH.AX) as of Sep 27, 2026 is 111.49 %. In the previous year, Capital Intensity Ratio was 120.57 % — a change of -7.53% (lower).

Capital Intensity

111.49 %

YoY

-7.53%

Last updated:

Capital Intensity Ratio of Cochlear is 2026 111.49 % . Capital Intensity Ratio of Cochlear was 2025 120.57 % . It decreases by -7.53% lower compared to the previous year.

The Cochlear Capital Intensity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Intensity
Date
Capital Intensity
Jan 1, 2019
96.67 AUD
Jan 1, 2020
191.02 AUD
Jan 1, 2021
162.47 AUD
Jan 1, 2022
150.21 AUD
Jan 1, 2023
132.67 AUD
Jan 1, 2024
122.79 AUD
Jan 1, 2025
120.57 AUD
Jan 1, 2026
111.49 AUD
The Cochlear Capital Intensity history
YEARCapital IntensityYoY
111.49 %-7.53%
120.57 %-1.81%
122.79 %-7.45%
132.67 %-11.67%
150.21 %-7.54%
162.47 %-14.95%
191.02 %+97.59%
96.67 %+13.95%
84.84 %-6.39%
90.63 %+7.02%
84.68 %-10.46%
94.57 %-3.52%
98.02 %—
Access this data via the Eulerpool API

Cochlear Stock analysis

What does Cochlear do? Cochlear Ltd is an Australian-based medical technology company founded in 1981 by engineer Professor Graeme Clark. The company specializes in Cochlear implant systems and other hearing devices. Cochlear Ltd offers accessories, services, and rehabilitation training for individuals with hearing impairments. The company's products are available for both children and adults with varying degrees of hearing loss. Cochlear Ltd operates in different sectors, including Cochlear implant systems, hearing aids, and wireless accessories and streaming systems under the brand names Nucleus® and Baha®. Nucleus® systems utilize a fully implantable cochlear implant and external speech processor to convert sound into electrical signals for interpretation by the brain. Baha® systems are bone-anchored hearing devices for individuals with unilateral to moderate hearing impairments. Cochlear Ltd also provides wireless accessories and streaming systems to connect devices like mobile phones, TVs, and music players to the hearing aids and cochlear implants, improving hearing performance and enhancing social lives. The company has a strong global presence, operating in over 100 countries with headquarters in Australia, multiple production facilities, and research centers. Cochlear Ltd has received numerous awards and recognition for its products and services and is committed to researching and developing new therapies and technologies to improve the lives of individuals with hearing impairments. Cochlear is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cochlear stock

Capital Intensity Ratio of Cochlear is 111.49 % in 2026.

Capital Intensity Ratio of Cochlear changed from 120.57 % to 111.49 %, representing a -7.53% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Capital Intensity Ratio Cochlear since 2006 – with annual values, charts, and detailed analysis.

Capital intensity measures the amount of assets needed to generate each unit of revenue. Lower ratios indicate asset-light business models.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Capital Intensity Ratio's Cochlear with sector peers and the industry average to assess whether it is attractive.

To evaluate Capital Intensity Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Capital Intensity Ratio.

Access this data via the Eulerpool API

Profitability — Cochlear

All Key Metrics — Cochlear